Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
32,648,161
-
Share change
-
+11,861,972
-
Total reported value
-
$483,839,331
-
Put/Call ratio
-
22%
-
Price per share
-
$14.82
-
Number of holders
-
96
-
Value change
-
+$177,178,450
-
Number of buys
-
74
-
Number of sells
-
25
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2020
As of 30 Jun 2020,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,648,161 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, BOXER CAPITAL, LLC, MPM ASSET MANAGEMENT LLC, BlackRock Inc., Avidity Partners Management LP, VANGUARD GROUP INC, FRAZIER MANAGEMENT LLC, ORBIMED ADVISORS LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
96
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.